1-7 of 7
Keywords: vaccine
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Biochem Soc Trans (2019) 47 (1): 251–264.
Published: 15 January 2019
... have effectively circulated in people in the past, there is a need for additional research to characterize currently circulating H2 influenza viruses. There is also a need to stockpile vaccines that are effective against both historical H2 laboratory isolates and H2 viruses currently circulating...
Biochem Soc Trans (2018) 46 (5): 1021–1027.
Published: 28 August 2018
... and the use of OMVs as vaccine delivery vehicles and other potential applications. Correspondence: Régis Stentz ( regis.stentz@quadram.ac.uk ) or Simon R. Carding ( simon.carding@quadram.ac.uk ) 13 5 2018 23 7 2018 24 7 2018 Gram-negative OMVs can use several routes to cross...
Biochem Soc Trans (2018) 46 (3): 691–698.
Published: 21 May 2018
...Joel D. Allen; Rogier W. Sanders; Katie J. Doores; Max Crispin The extensive post-translational modifications of the envelope spikes of the human immunodeficiency virus (HIV) present considerable challenges and opportunities for HIV vaccine design. These oligomeric glycoproteins typically have over...
Biochem Soc Trans (2007) 35 (4): 833–834.
Published: 20 July 2007
...C. Rhyner; T. Kündig; C.A. Akdis; R. Crameri The worldwide increase in the incidence of allergic diseases and the limited efficacy of current vaccines require the development of new efficient vaccination strategies. Based on PTD (protein transduction domain) technology, we have engineered MAT...
Biochem Soc Trans (2004) 32 (4): 626–628.
Published: 01 August 2004
...C.A.L.S. Colaco; C.R. Bailey; J. Keeble; K.B. Walker The need for an effective TB (tuberculosis) vaccine remains acute, with tuberculosis still one of the major killers worldwide and 3 million new infections annually. We report here on the immune responses elicited by HspCs (heat-shock protein...
Biochem Soc Trans (2002) 30 (4): 574–578.
Published: 01 August 2002
.... 1 To whom correspondence should be addressed, at the Department of Neurology, New York University Medical Center (e-mail thomas.wisniewski@med.nyu.edu ) 10 4 2002 © 2002 Biochemical Society 2002 amyloid-β conformation treatment vaccine AD, Alzheimer's disease Aβ...
Biochem Soc Trans (2000) 28 (5): 527–531.
Published: 01 October 2000
... in Leishmania . To whom correspondence should be addressed (e-mail mylerpj@sbri.org ) 30 6 2000 © 2000 Biochemical Society 2000 genome sequencing regulatable promoter serodiagnosis transcription vaccine Chr, chromosome LD1, Leishmania DNA 1 LmjF, Leishmania major Friedlin...